期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌干细胞分选方法研究进展 被引量：2

Advances of Breast Cancer Stem Cell Isolation
下载PDF
导出
摘要 乳腺癌干细胞是来源于正常乳腺干细胞或分化乳腺细胞,具有自我更新能力、分化能力、致瘤性特征及对放疗、化疗、内分泌治疗抵抗的乳腺癌细胞。目前分离乳腺癌干细胞的方法主要有CD44+CD24-/low Lin-、乙醛脱氢酶1(ALDH1)、乳腺球、侧群细胞、DNA标记滞留细胞及改良分选方法等。本文将就近年来乳腺癌干细胞分选方法的研究进展做一综述。 Breast cancer stem cells were originated from the normal mammary stern cells or the differentiated breast cancer cells, featured with the ability of self-renewal, differentiation, tumorigenicity. They were found more resistant to cancer chemo- therapy, hormone therapy and radiotherapy. At present, surface markers CD44＋CD24-/low Lin-, ALDH1 assay, mammos- pheres, side population cells, label retaining cells and improved separation methods were mainly applied to isolate breast cancer stem cells. This paper was aimed to review the advances of the methods of breast cancer stem cell isolation.
作者 文波 刘红光
机构地区 南华大学附属第一医院肿瘤外科
出处 《肿瘤药学》 CAS 2013年第5期335-339,共5页 Anti-Tumor Pharmacy
关键词 乳腺癌干细胞 分选方法 DNA标记 Breast cancer stem cell Isolation DNA label
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献31

  • 1Jemal A,Bray F,Center MM. Global cancer statistics[J].CA:Cancer J Clin,2011,(02):69-90.
  • 2全国肿瘤防治研究办公室;全国肿瘤登记中心;卫生部疾病预防控制局.中国肿瘤死亡报告--全国第三次死因回顾抽样调查[M]{H}北京:人民卫生出版社,2010120-131.
  • 3Nicolini A,Ferrari P,Fini M. Stem cells:their role in breast cancer development and resistance to treatment[J].Curr Pharmaceut Biotechnol,2011,(02):196-205.
  • 4Bonnet D,Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].{H}Nature Medicine,1997,(07):730-737.
  • 5Al-Hajj M,Wicha MS,Benito-Hernandez A. Pro-spective identification of tumorigenic breast cancer cell[J].{H}Proceedings of the National Academy of Sciences(USA),2003,(07):3983-3988.
  • 6Ponti D,Costa A,Zaffaroni N. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J].{H}CANCER RESEARCH,2005,(13):5506-5511.
  • 7Polyak K. Breast cancer:origins and evolution[J].{H}Journal of Clinical Investigation,2007,(11):3155-3163.
  • 8Burns JS,Abdallah BM,Guldberg P. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells[J].{H}CANCER RESEARCH,2005,(08):3126-3135.
  • 9R?sland GV,Svendsen A,Torsvik A. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant trans-formation[J].{H}CANCER RESEARCH,2009,(13):5331-5339.
  • 10Takahashi K,Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].{H}CELL,2006,(04):663-676.doi:10.1016/j.cell.2006.07.024.

二级参考文献27

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量：278
  • 2Bao S, Wu Q, Mclendon R E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J]. Nature, 2006,444(7120) :756-760.
  • 3Phillips T M, Mcbride W H, Pajonk F. The response of CD24 (-/low)/CD44+ breast cancer-initiating ceils to radiation [J]. J Natl Cancer Inst, 2006,98(24) : 1777-1785.
  • 4Blazek E R, Foutch J L, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133^+ sector is enlarged by hypoxia [J]. Int J Radiat Oncol Biol Phys, 2007,67 ( 1 ) : 1-5.
  • 5Hambardzumyan D, Becher O J, Rosenblum M K, et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo [J]. Genes Dev, 2008,22(4):436-448.
  • 6Chen M S, Woodward W A, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of Seal + progenitors in an immortalized mammary gland cell line [J]. J Cell Sci, 2007, 120(Pt 3) :468-477.
  • 7Al-Hajj M, Wicha M S, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer ceils [J]. Proc Natl Acad Sci U S A, 2003,100(7):3983-3988.
  • 8Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2 + and ABCG2- cancer cells are similarly tumorigenic [J]. Cancer Res, 2005,65(14) :6207-6219.
  • 9Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties [ J ]. Cancer Res, 2005,65 ( 13 ) : 5506- 5511.
  • 10Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998[J]. J Clin Oncol, 2003,21 (1) : 28-34.

共引文献12

同被引文献47

  • 1李治,黄韬,贺艳丽,张家华,张景辉,田元.乳腺癌干细胞逃逸化疗机制的研究[J].中华实验外科杂志,2007,24(1):20-21. 被引量：20
  • 2李治,刘春萍,贺艳丽,张景辉,黄韬.乳腺癌干细胞BCRP的表达及意义[J].医学分子生物学杂志,2007,4(6):511-513. 被引量：4
  • 3盛佳钰,陈红风.乳腺癌的上皮间质转化与多药耐药[C]//第十三届全国中医及中西医结合乳腺病学术年会论文集2013:160-164.
  • 4蒋国勤,袁年勇,何建刚.白杨素逆转乳腺癌干细胞的耐药性实验研究[C]//江苏省第四次乳腺甲状腺内分泌外科学术会议论文集.2009:50-53.
  • 5Hardt O, Wild S, Oerlecke I, et al. Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett. 2012;325(2): 165-174.
  • 6Singh JK, Simoes BM, Clarke RB, et al. Targeting IL-8 signalling to inhibit breast cancer stem cell activity. Expert Opin Ther Targets. 2013;17(11):1235-1241.
  • 7RodyA, Karn T, Holtrich U, et al. "Stem cell like" breasl cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1. Eur J Obstet Gynecol Reprod Biol. 2008; 139(1 ): 11-15.
  • 8Buckley NE, Nic An tSaoir CB, Blayney JK, et al. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Nucleic Acids Res. 2013;41 (18):8601-8614.
  • 9Tchokouaha RF, Alexi X, Chosson E, et al. Erymildbraedin A and B, two novel cytotoxic dimethylpyrano-isoflavones from the stem bark of Erythrina mildbraedii: evaluation of their activity toward endocrine cancer cells. J Enzyme Inhib Med Chem. 2010;25(2):228-233.
  • 10Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res. 2009; 15(12):4234-4241.

引证文献2

二级引证文献4

肿瘤药学
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部